NCT05136755: NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
- State
- Under way
- Phase
- Phase 2
- People
- 50 planned
- Started
- 25 Jan 2022
- Primary completion
- Nov 2026
- Arms
- NMDAE
- Results
- None posted
- 29 Nov 2021: Trial registered
- 25 Jan 2022: Trial started